TribLIVE

| Home


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AGH heart specialists to join clinical trial

Daily Photo Galleries

Wednesday, March 14, 2012
 

Heart specialists at Allegheny General Hospital announced today that they will join a clinical trial investigating an implantable device designed to provide patients with coronary artery disease an early warning of an impending heart attack.

AGH is the only Pittsburgh area hospital testing the new device — the AngelMed Guardian System.

"Patient outcomes following heart attack are largely dependent upon how quickly the cardiac injury is diagnosed and therapeutic efforts are initiated to restore blood flow to the heart. Delays in that process can result in permanent damage to heart muscle," said Dr. David Lasorda, director of the hospital's division of Interventional cardiology and its principal investigator in the study.

The American Heart Association estimates that one of every five deaths in the United States is attributable to coronary heart disease. Furthermore, 50 percent of heart-attack fatalities occur within one hour of symptom onset and often before the patient even reaches the hospital.

 

 
 


Show commenting policy

Most-Read Stories

  1. CDC’s misinformation spreads faster than Ebola virus
  2. Pirates must weigh risk, reward in attempt to sign Martin
  3. Pa. Supreme Court in ‘sad state’ as scandals tarnish reputation
  4. Penguins rebound with shutout of Predators
  5. Syrian border town emerges as pivot point in Islamic State fight
  6. Real estate notes: Hotel going up in Chippewa; CSX honored
  7. Experience ‘Faces and Voices’
  8. Penn State succumbs to No. 13 Ohio State in double overtime
  9. Robinson: Rooney retains North Side roots
  10. Starkey: Chryst missed his only shot
  11. Steelers notebook: Ex-Steeler Sanders living up to his word
Subscribe today! Click here for our subscription offers.